Carol Sze Ki Leung

  • Fellowship in 2010 at the University of Zurich
  • Scholarship in 2005 at Birmingham University

Carol has just started working as a Principal Research Fellow in UCL Cancer Institute after she finished her postdoctoral training in the University of Zurich in April 2014. The Croucher Foundation not only funded her postdoctoral training in Zurich, but also supported her PhD study in the University of Birmingham in the UK after she received her BSc and MPhil degrees in the University of Hong Kong.

Currently

She works on a vaccine development against Epstein-Barr virus (EBV) and HIV infection. The vaccine strategy is to target the EBV or HIV antigens to dendritic cells (DCs) by incorporating the antigens into an antibody against the DC endocytic receptor DEC-205. She is currently investigating the protective effect of this vaccine strategy in a mouse model with reconstituted human immune system components.